News: Home Page Latest News

Next Page »« Previous Page

Weaver Honored by Neuro Association

Friday, June 10th, 2011

Kyle Weaver, M.D., assistant professor of Neurological Surgery, has received the Preuss Award from the Joint Section on Tumors of the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS). The Preuss Award is given to a young scientist investigating brain tumors who submitted the best basic science research paper. First […]

Vanderbilt Opens New Lymphedema Clinic

Thursday, May 26th, 2011

For the first time, Vanderbilt is providing specialized services for patients who are experiencing lymphedema, a chronic debilitating condition which is the result of an accumulation of protein-rich fluid in tissues. The fluid retention can cause severe swelling, pain, skin ulcerations and impaired mobility, and once present, the condition continues to progress. The new Vanderbilt […]

Magnet to Enhance Cancer Drug Discovery

Friday, May 13th, 2011

Onlookers cheered early on the morning of Saturday, May 7, as a shattering champagne bottle christened the delivery of a $5 million, 7.5-ton magnet to Vanderbilt University. The magnet is the main part of an ultra-high field, 900 megahertz nuclear magnetic resonance (NMR) spectrometer that will help researchers solve the mysteries of cancer, Alzheimer’s disease […]

Patients Show Benefit from Melanoma Drug

Friday, May 6th, 2011

On Mother’s Day 2008, Marcia Akers was expecting a traditional Mother’s Day gift from her children. Instead, she received a piercing pain, like a lightning bolt streaking down the right side of her body. The seizure resulted in a trip to a Nashville hospital where tests revealed a golf ball-size tumor in her brain. Doctors […]

Medical Honor Society Inducts Pao, Polack

Friday, April 22nd, 2011

William Pao, M.D., Ph.D., and Fernando Polack, M.D., have been elected into one of the nation’s most respected medical honor societies — the American Society for Clinical Investigation (ASCI). Pao, the Ingram Associate Professor of Cancer Research, and Polack, the Cesar Milstein Associate Professor of Pediatrics, were among 70 new members introduced at the ASCI […]

VICC Investigators Shine at Conference

Friday, April 15th, 2011

Lynn Matrisian, Ph.D., chair of the Department of Cancer Biology, has been named to the Nominating Committee for the American Association for Cancer Research (AACR). The announcement was made during the AACR annual meeting held earlier this month in Orlando, Fla. Matrisian has served as AACR president from 2004-2005, as a member of the board […]

Celebrate Survivors’ Day on June 18

Thursday, April 7th, 2011

Vanderbilt-Ingram Cancer Center cordially invites you and your guests to join us for this year’s Survivors’ Day Conference, “Cancer GPS: Navigating Your Journey” on Saturday, June 18, 2011. The event will be held at Vanderbilt University Student Life Center from 10 a.m. – 4 p.m. Linda Armstrong Kelly, the mother of Lance Armstrong, will be the keynote speaker. During your lunch break, […]

$10 Million Grant Bolsters Molecular Imaging

Friday, April 1st, 2011

The National Center for Research Resources has awarded Vanderbilt University $10.3 million over the next five years to establish a National Research Resource for Imaging Mass Spectrometry. Richard Caprioli, Ph.D., director of Vanderbilt’s Mass Spectrometry Research Center, is leading the program. Imaging mass spectrometry is a tool for visualizing the location of proteins in cells […]

Study Snuffs Out Menthol Myths

Friday, March 25th, 2011

People who smoke mentholated cigarettes are no more likely to develop lung cancer or to die from the disease than smokers of non-mentholated cigarettes, according to a new study led by Vanderbilt-Ingram Cancer Center’s William Blot, Ph.D., and colleagues at Meharry Medical College and the International Epidemiology Institute, Rockville, Md. The new smoking study was […]

Breast Cancer Study Combines Therapies

Friday, March 18th, 2011

Combining targeted therapies might be required for maximum anti-tumor activity when treating HER2-positive breast cancers, according to two new studies by Vanderbilt-Ingram Cancer Center (VICC) investigators. The findings, reported in two papers in the Proceedings of the National Academy of Sciences (PNAS), suggest that upregulation of the HER3 receptor limits the effectiveness of two classes […]